These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 15816795

  • 1. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 2. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S, Quercioli L, Bruscoli M.
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [Abstract] [Full Text] [Related]

  • 3. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD, Birkett M, Koran L, Genduso L.
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [Abstract] [Full Text] [Related]

  • 4. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [Abstract] [Full Text] [Related]

  • 5. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A.
    Biol Psychiatry; 2006 Jun 01; 59(11):1071-7. PubMed ID: 16497273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.
    Greenberg WM, Benedict MM, Doerfer J, Perrin M, Panek L, Cleveland WL, Javitt DC.
    J Psychiatr Res; 2009 Mar 01; 43(6):664-70. PubMed ID: 19046587
    [Abstract] [Full Text] [Related]

  • 9. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
    Grant JE, Kim SW, Odlaug BL.
    Biol Psychiatry; 2007 Sep 15; 62(6):652-7. PubMed ID: 17445781
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.
    Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E.
    Compr Psychiatry; 2010 Sep 15; 51(4):373-9. PubMed ID: 20579510
    [Abstract] [Full Text] [Related]

  • 12. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar 15; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 13. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M, Gama CS, Sundram S, Hustig H, Koopowitz L, D'Souza R, Malloy H, Rowland C, Monkhouse A, Monkhouse A, Bole F, Sathiyamoorthy S, Piskulic D, Dodd S.
    Hum Psychopharmacol; 2009 Apr 15; 24(3):233-8. PubMed ID: 19330802
    [Abstract] [Full Text] [Related]

  • 14. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul 15; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 15. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD, Kerwin L, Saxena S, Bystritsky A.
    Psychopharmacol Bull; 2009 Jul 15; 42(1):81-93. PubMed ID: 19204653
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nicotine treatment of obsessive-compulsive disorder.
    Lundberg S, Carlsson A, Norfeldt P, Carlsson ML.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov 15; 28(7):1195-9. PubMed ID: 15610934
    [Abstract] [Full Text] [Related]

  • 18. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Nov 15; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 19. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
    DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P.
    J Am Acad Child Adolesc Psychiatry; 1992 Jan 15; 31(1):45-9. PubMed ID: 1537780
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.